Inhibition of toll-like receptor 4 alleviates hyperalgesia induced by acute dural inflammation in experimental migraine
Authors:
Open Access
- 8 January 2018
- journal article
- research article
- Published by SAGE Publications in Molecular Pain
- Vol. 14
Abstract
Objective: Although nociceptive sensitisation is an important pathophysiological process in migraine and migraine chronification, its underlying mechanisms remain unclear. Toll-like receptor 4 (TLR4), a pattern-recognition molecule, has a critical role in both neuropathic pain and morphine tolerance. The present study examined whether elements of the TLR4 pathway contribute to hyperalgesia induced by dural inflammation in rats. Methods: A rat model of migraine was established by infusing a dural inflammatory soup. A group pretreated with TAK-242 was used to inhibit the activation of TLR4. The protein levels of TLR4 and its downstream molecules in the trigeminal pathway were examined by Western blot and immunofluorescence. The expression of activated microglia and astrocytes was also analysed. Levels of interleukin-1 beta, tumour necrosis factor-alpha, and brain-derived neurotrophic factor were measured by enzyme-linked immunosorbent assay. Results: Acute inflammatory soup infusion induced time-dependent facial mechanical hyperalgesia, which was blocked by TAK-242 pretreatment. The inflammatory soup stimulus increased the production of TLR4 downstream molecules and interleukin-1 beta. Higher levels of microglia activation and brain-derived neurotrophic factor release were observed following the administration of the inflammatory soup but were alleviated by TAK-242. Conclusions: These data suggest that the TLR4 signalling pathway promotes hyperalgesia induced by acute inflammatory soup delivery by stimulating the production of proinflammatory cytokines and activating microglia.Keywords
This publication has 30 references indexed in Scilit:
- A chronic animal model of migraine, induced by repeated meningeal nociception, characterized by a behavioral and pharmacological approachCephalalgia, 2013
- Central sensitization: Implications for the diagnosis and treatment of painPain, 2011
- Pattern Recognition Receptors and InflammationCell, 2010
- The “Toll” of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting GliaTrends in Pharmacological Sciences, 2009
- Medullary pain facilitating neurons mediate allodynia in headache‐related painAnnals of Neurology, 2009
- Glial TLR4 receptor as new target to treat neuropathic pain: Efficacy of a new receptor antagonist in a model of peripheral nerve injury in miceGlia, 2008
- Clarification of Developing and Established Clinical Allodynia and Pain‐Free OutcomesHeadache: The Journal of Head and Face Pain, 2007
- Nuclear Factor κB Signaling in Opioid Functions and Receptor Gene ExpressionJournal of Neuroimmune Pharmacology, 2006
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Ethical guidelines for investigations of experimental pain in conscious animalsPain, 1983